Two-year results from an open-label, multicentre, phase III study evaluating the safety and efficacy of canakinumab in patients with cryopyrin-associated periodic syndrome across different severity phenotypes (Q57612974)
Jump to navigation
Jump to search
scientific article published on 21 August 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Two-year results from an open-label, multicentre, phase III study evaluating the safety and efficacy of canakinumab in patients with cryopyrin-associated periodic syndrome across different severity phenotypes |
scientific article published on 21 August 2011 |
Statements
Two-year results from an open-label, multicentre, phase III study evaluating the safety and efficacy of canakinumab in patients with cryopyrin-associated periodic syndrome across different severity phenotypes (English)
Jasmin B Kuemmerle-Deschner
R Cartwright
P N Hawkins
T A Tran
J Hoyer
M Gattorno
A Gul
J Smith
K S Leslie
S Jiménez
S Morell-Dubois
N Davis
N Patel
A Widmer
21 August 2011